Optimal Meals to Reduce Bone Resorption in Women With Osteopenia
Launched by UNIVERSITY OF AARHUS · Jul 8, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether different small meals can help slow down bone loss in postmenopausal women who have osteopenia, a condition where bones are weaker than normal but not yet osteoporosis. The researchers want to find out if a small dairy drink (like 100 ml of milk) works as well as a larger snack that includes dairy and a banana in reducing bone breakdown. By testing five different meals and comparing them to a day without eating, they hope to discover which meal type and size best supports bone health.
Women who might join this study are postmenopausal, under 80 years old, have a certain level of bone thinning in their lower back, and a body weight within a healthy range. Participants will visit the clinic six times—five times to try different meals and once without eating—to have blood samples taken over six hours after each visit. These samples will help measure how the meals affect bone health. The study aims to find a simple, food-based way to protect bones and possibly prevent osteoporosis, without using medications.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Osteopenia at the lumbar spine defined as BMD t-score -2.4 to -1.1.
- • Postmenopausal women
- • Age \< 80 years
- • CTX level ≥ 0.40 ng/ml
- • BMI 17-25 kg/m2
- Exclusion Criteria:
- • A diagnosis of osteoporosis, diabetes, primary hyperparathyroidism or active malignancy.
- • Current or recent (within two years) use of systemic glucocorticoids for 4 continuous weeks or more, anticonvulsants or anti-osteoporotic drugs including systemic estrogen treatment.
- • Low p-25-OH vitamin D-levels (\< 50 pmol/l)
- • Estimated glomerular filtration (eGFR) \<60 ml/min
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, , Denmark
Patients applied
Trial Officials
Jakob S Linde, Medical Doctor, MD, PhD
Principal Investigator
Department of Endocrinology and Internal Medicine, Aarhus University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported